WO2001087907A3 - Haplotypes du gene de l'osm - Google Patents

Haplotypes du gene de l'osm Download PDF

Info

Publication number
WO2001087907A3
WO2001087907A3 PCT/US2001/016157 US0116157W WO0187907A3 WO 2001087907 A3 WO2001087907 A3 WO 2001087907A3 US 0116157 W US0116157 W US 0116157W WO 0187907 A3 WO0187907 A3 WO 0187907A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
osm
gene
disclosed
osm gene
Prior art date
Application number
PCT/US2001/016157
Other languages
English (en)
Other versions
WO2001087907A2 (fr
Inventor
Amy E Duda
Amir Kazemi
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Amy E Duda
Amir Kazemi
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Amy E Duda, Amir Kazemi, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2001264681A priority Critical patent/AU2001264681A1/en
Publication of WO2001087907A2 publication Critical patent/WO2001087907A2/fr
Publication of WO2001087907A3 publication Critical patent/WO2001087907A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne de nouveaux variants génétiques du gène de l'oncostatine M (OSM). L'invention se rapporte à divers génotypes, haplotypes et paires d'haplotypes du gène de l'OSM que l'on retrouve en général dans la population des Etats-Unis. L'invention concerne des compositions et des procédés d'haplotypage et/ou génotypage du gène de l'OSM chez un individu. L'invention se rapporte enfin à des polynucléotides définis par la séquence des haplotypes précités.
PCT/US2001/016157 2000-05-17 2001-05-17 Haplotypes du gene de l'osm WO2001087907A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264681A AU2001264681A1 (en) 2001-05-17 2001-05-17 Haplotypes of the osm gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20486800P 2000-05-17 2000-05-17
US60/204,868 2000-05-17

Publications (2)

Publication Number Publication Date
WO2001087907A2 WO2001087907A2 (fr) 2001-11-22
WO2001087907A3 true WO2001087907A3 (fr) 2002-04-11

Family

ID=22759790

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016157 WO2001087907A2 (fr) 2000-05-17 2001-05-17 Haplotypes du gene de l'osm

Country Status (1)

Country Link
WO (1) WO2001087907A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1327639A1 (fr) * 2002-01-15 2003-07-16 Bayer Ag Prédiction de maladies cardiovasculaires par polymorphisme génétique de genes associés à ces maladies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521301A (en) * 1988-12-12 1996-05-28 City Of Hope Genotyping of multiple allele systems
US5851762A (en) * 1990-07-11 1998-12-22 Gene Type Ag Genomic mapping method by direct haplotyping using intron sequence analysis
US5874536A (en) * 1989-12-08 1999-02-23 Bristol-Myers Squibb Company Proteins with Oncostatin M activity and process for their preparation
WO1999041364A2 (fr) * 1998-02-13 1999-08-19 The Wistar Institute Compositions et methodes de cicatrisation de lesions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521301A (en) * 1988-12-12 1996-05-28 City Of Hope Genotyping of multiple allele systems
US5874536A (en) * 1989-12-08 1999-02-23 Bristol-Myers Squibb Company Proteins with Oncostatin M activity and process for their preparation
US5851762A (en) * 1990-07-11 1998-12-22 Gene Type Ag Genomic mapping method by direct haplotyping using intron sequence analysis
WO1999041364A2 (fr) * 1998-02-13 1999-08-19 The Wistar Institute Compositions et methodes de cicatrisation de lesions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAI-QING ET AL.: "Molecular cloning and expression of oncostatin M", CHINESE BIOCHEMICAL JOURNAL, vol. 13, no. 3, June 1997 (1997-06-01), pages 259 - 263, XP002905194 *
MA ET AL.: "Cloning and characterization of human oncostatin M promoter", NUCLEIC ACIDS RESEARCH, vol. 27, no. 23, 1999, pages 4649 - 4657, XP002905193 *

Also Published As

Publication number Publication date
WO2001087907A2 (fr) 2001-11-22

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002038586A3 (fr) Haplotypes du gene il6
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2001098315A3 (fr) Haplotypes du gene hmgcl
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002044201A3 (fr) Haplotypes du gene sah
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP